首页 | 官方网站   微博 | 高级检索  
     

膀胱癌EJ细胞的CD44异常糖基化及其单抗KMP1的生物学功能研究
引用本文:丁明霞,李翀,左毅刚,詹辉,范祖森,王剑松.膀胱癌EJ细胞的CD44异常糖基化及其单抗KMP1的生物学功能研究[J].中国肿瘤临床,2011,38(13):759-762.
作者姓名:丁明霞  李翀  左毅刚  詹辉  范祖森  王剑松
作者单位:昆明医学院第二附属医院泌尿外科,云南省泌尿外科研究所 (昆明市650101)
基金项目:本文课题受昆明医学院研究生创新基金项目
摘    要:研究EJ细胞单抗KMP1的结合抗原CD44的变化和KMP1对EJ细胞生物学功能的影响。方法:采用人膀胱癌EJ细胞株免疫BALB/c小鼠,获得单抗KMP1,免疫荧光检测KMP1的亲和性、结合部位及效价。流式细胞检测KMP1对膀胱癌细胞的特异性。免疫组化检测对膀胱癌组织的特异性。亲和层析分离纯化特异性抗原,检测抗原的氨基酸序列。糖基转化酶抑制剂和过碘酸氧化后分析抗原决定簇的理化性质改变。软琼脂培养克隆形成实验和细胞划痕实验检测KMP1对EJ细胞株的增殖和迁移功能的影响。结果:获得的单抗KMP1是IgG1,能与EJ、BIU-87、T24膀胱癌细胞和膀胱癌组织特异性结合,而与Lovo、HeLa、K562、HepG2、Jurkat、293、HCV29、人的红细胞和白细胞无结合性,也不能结合正常膀胱黏膜。其结合EJ细胞的抗原是异常糖基化的CD44,糖基转化酶抑制剂BG作用EJ细胞7d,KMP1对EJ细胞结合性降低,过碘酸氧化后Western blot显示KMP1对CD44结合性降低,软琼脂培养克隆形成实验和细胞划痕实验结果示KMP1还能减弱EJ细胞的增殖和迁移功能。结论:膀胱癌的高复发性、易转移可能与出现异常糖基化的CD44高表达具有一定的相关性,KMP1可结合异常糖基化的CD44,并抑制EJ细胞的增殖和迁移。 

关 键 词:膀胱癌    EJ细胞    单克隆抗体    CD44    糖基化
收稿时间:2011-04-13

Aberrant Glycosylation of CD44 in Oncogenesis of EJ Cells and Biological Effects of Anti-CD44 Monoclonal Antibody KMP1
Mingxia DING,Chong LI,Yigang ZUO,Hui ZHAN,Zusen ZHAN,Jiansong WANG.Aberrant Glycosylation of CD44 in Oncogenesis of EJ Cells and Biological Effects of Anti-CD44 Monoclonal Antibody KMP1[J].Chinese Journal of Clinical Oncology,2011,38(13):759-762.
Authors:Mingxia DING  Chong LI  Yigang ZUO  Hui ZHAN  Zusen ZHAN  Jiansong WANG
Affiliation:Department of Urinary Surgery, Second Affiliated Hospital of Kunming Medical College, Yunnan Institute of Urologic Research, Kunming 650101, China
Abstract:To examine the variation in the antigen CD44 when immuno-conjugated with the monoclonal antibody KMP1 and the biological effects of KMP1 on EJ cells. Methods: KMP1, the antibody against bladder cancer that could recognize the aberrantly glycosylated CD44 of human EJ cells, was obtained from BALB/c mice. ELISA was used to determine the affinity, binding site, and valence of this antibody. Flow cytometry and immunohistochemistry were conducted to detect the specificity of this antigen on the EJ cells and cancer tissues. The specific antigen was separated and purified by affinity chromatography, and its amino acid sequence was determined. After glycosyltransferase inhibition by benzyl-N-acetyl-d-galactosaminide ( BG ) and mild periodate oxidation, the variation in the physico-chemical property of the antigenic determinant was analyzed. Soft agar clone formation and wound healing assays were performed to investigate the effect of KMP1 on the proliferation and migration of the EJ cells. Results: KMP1 was an IgG1 antibody that can be specifically bound to the EJ, BIU-87, and T24 cell lines as well as to bladder carcinoma tissue, but not to the Lovo, HeLa, K562, HepG2, Jurkat, 293, HCV29 cell lines, the human red blood cell, human lymphocytes, or normal bladder tissue. KMP1 recognizes aberrantly glycosylated CD44 of EJ cells. BG inhibited the conjugation of KMP1 and EJ cells. KMP1 inhibits cancerous proliferation and migration of the EJ cells. Conclusions: The high recurrence and metastasis of the bladder carcinoma may be in a definite relation to the high expression of CD44 with aberrant glycosylation. KMP1 can bind the aberrantly glycosylated CD44 and inhibit the proliferation and migration of the EJ cells. 
Keywords:CD44
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号